Whole-genome sequencing of 490,640 UK Biobank participants
Magnús Ö. Úlfarsson(deCODE Genetics (Iceland)), Keren Carss(University of Cambridge), Robert A. Scott(MRC Epidemiology Unit), Hannes Hauswedell(deCODE Genetics (Iceland)), Kieren Lythgow(AstraZeneca (United Kingdom)), Menelas N. Pangalos(AstraZeneca (United Kingdom)), Trevor Howe(Janssen (United Kingdom)), Kāri Stefánsson(deCODE Genetics (Iceland)), Karyn Mégy(NHS Blood and Transplant), Hannes P. Eggertsson(deCODE Genetics (Iceland)), Neil Marriott(Wellcome Sanger Institute), Svanhvít Sigurjónsdóttir(deCODE Genetics (Iceland)), Fengyuan Hu(Babraham Institute), Ahmet Sinan Yavuz, Liping Hou(Janssen (United States)), Katherine R. Smith(Murdoch Children's Research Institute), Carolina Haefliger(AstraZeneca (United Kingdom)), Oliver S. Burren(AstraZeneca (United Kingdom)), Kousik Kundu(University of Cambridge), Peter Maccallum(AstraZeneca (United Kingdom)), Eleanor Wheeler(AstraZeneca (United Kingdom)), Ryan S. Dhindsa(Baylor College of Medicine), Zhuoyi Huang(Baylor College of Medicine), Jonathan Mitchell(AstraZeneca (United Kingdom)), Ben Lacey(UK Biobank), Adrián Cortés(Institut thématique Génétique, génomique et bioinformatique), Mary Helen Black(Takeda (United States)), Ruth March(AstraZeneca (United Kingdom)), Ögmundur Eiríksson(deCODE Genetics (Iceland)), Jelena Randjelović, Quanli Wang, Sean M. O’Dell(AstraZeneca (United States)), Aron Skaftason(deCODE Genetics (Iceland)), Sebastian Wasilewski(AstraZeneca (United Kingdom)), Kristjan H. S. Moore(deCODE Genetics (Iceland)), Yancy Lo(Institut thématique Génétique, génomique et bioinformatique), Haeyam Taiy(AstraZeneca (United Kingdom)), Shuwei Li(Springhouse), Jimmy Z. Liu(Wellcome Sanger Institute), Slavé Petrovski(The Royal Melbourne Hospital), Ian Johnston(Wellcome Sanger Institute), Sri V. V. Deevi(University of Cambridge), Amanda O’Neill(University of Cambridge), Diana Rajan(Wellcome Sanger Institute), Bjarni V. Halldórsson(deCODE Genetics (Iceland)), Nokkvi Gislason(deCODE Genetics (Iceland))
Cited by 89
Related Papers
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.7k
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
|Nature Genetics|2006|2.3k
Large recurrent microdeletions associated with schizophrenia
|Nature|2008|1.8k